Table 3.
Spearman analysis of correlation between DPT and clinicopathological
| Variables | DPT expression level | |
|---|---|---|
| Spearman correlation | p value | |
| Age (years, <50 vs. ≥50) | -0.255 | 0.049 |
| Gender (male/female) | 0.059 | 0.655 |
| Alcoholism (yes/no) | -0.282 | 0.029 |
| Liver cirrhosis (yes/no) | 0.073 | 0.578 |
| AFP (ng/L, <200 vs. ≥200) | 0.024 | 0.858 |
| ALT (U/L, <60 vs. ≥60) | -0.197 | 0.132 |
| AST (U/L, <40 vs. ≥40) | -0.189 | 0.149 |
| Tumor number (single/multiple) | 0.163 | 0.212 |
| Tumor size (cm, <5 vs. ≥5) | -0.001 | 0.993 |
| Portal vein invasion (yes/no) | 0.139 | 0.290 |
| TNM stage (I+II vs III+IV) | -0.183 | 0.161 |
Bold numbers indicate significant differences (P < 0.05). HCC, hepatocellular carcinoma; AFP, α-fetoprotein; ALT, alanine aminotransferase; AST, aspartate aminotransferase; TNM, tumor node metastasis.